BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mantovani G, Macciò A, Madeddu C, Serpe R, Massa E, Dessì M, Panzone F, Contu P. Randomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexia. Oncologist 2010;15:200-11. [PMID: 20156909 DOI: 10.1634/theoncologist.2009-0153] [Cited by in Crossref: 119] [Cited by in F6Publishing: 104] [Article Influence: 9.9] [Reference Citation Analysis]
Number Citing Articles
1 Ruiz Garcia V, López-Briz E, Carbonell Sanchis R, Gonzalvez Perales JL, Bort-Marti S. Megestrol acetate for treatment of anorexia-cachexia syndrome. Cochrane Database Syst Rev. 2013;3:CD004310. [PMID: 23543530 DOI: 10.1002/14651858.cd004310.pub3] [Cited by in Crossref: 55] [Cited by in F6Publishing: 48] [Article Influence: 6.1] [Reference Citation Analysis]
2 Mondello P, Mian M, Aloisi C, Famà F, Mondello S, Pitini V. Cancer Cachexia Syndrome: Pathogenesis, Diagnosis, and New Therapeutic Options. Nutrition and Cancer 2014;67:12-26. [DOI: 10.1080/01635581.2015.976318] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 4.1] [Reference Citation Analysis]
3 Mitchell T, Clarke L, Goldberg A, Bishop KS. Pancreatic Cancer Cachexia: The Role of Nutritional Interventions. Healthcare (Basel) 2019;7:E89. [PMID: 31323984 DOI: 10.3390/healthcare7030089] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
4 Mantovani G, Madeddu C, Serpe R. Improvement of physical activity as an alternative objective variable to measure treatment effects of anticachexia therapy in cancer patients. Current Opinion in Supportive & Palliative Care 2010;4:259-65. [DOI: 10.1097/spc.0b013e32833b35c0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
5 Advani SM, Advani PG, VonVille HM, Jafri SH. Pharmacological management of cachexia in adult cancer patients: a systematic review of clinical trials. BMC Cancer 2018;18:1174. [PMID: 30482179 DOI: 10.1186/s12885-018-5080-4] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 11.0] [Reference Citation Analysis]
6 Mattox TW. Cancer Cachexia: Cause, Diagnosis, and Treatment. Nutr Clin Pract 2017;32:599-606. [PMID: 28825869 DOI: 10.1177/0884533617722986] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 6.2] [Reference Citation Analysis]
7 Jiménez A, Madero R, Alonso A, Martínez-marín V, Vilches Y, Martínez B, Feliu M, Díaz L, Espinosa E, Feliu J. Symptom Clusters in Advanced Cancer. Journal of Pain and Symptom Management 2011;42:24-31. [DOI: 10.1016/j.jpainsymman.2010.10.266] [Cited by in Crossref: 60] [Cited by in F6Publishing: 50] [Article Influence: 5.5] [Reference Citation Analysis]
8 Mantovani G, Madeddu C, Macciò A. Drugs in development for treatment of patients with cancer-related anorexia and cachexia syndrome. Drug Des Devel Ther 2013;7:645-56. [PMID: 23976842 DOI: 10.2147/DDDT.S39771] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
9 Ma YJ, Yu J, Xiao J, Cao BW. The consumption of omega-3 polyunsaturated fatty acids improves clinical outcomes and prognosis in pancreatic cancer patients: a systematic evaluation. Nutr Cancer. 2015;67:112-118. [PMID: 25425246 DOI: 10.1080/01635581.2015.976315] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
10 Tomlinson D, Robinson PD, Oberoi S, Cataudella D, Culos-Reed N, Davis H, Duong N, Gibson F, Götte M, Hinds P, Nijhof SL, van der Torre P, Cabral S, Dupuis LL, Sung L. Pharmacologic interventions for fatigue in cancer and transplantation: a meta-analysis. Curr Oncol 2018;25:e152-67. [PMID: 29719440 DOI: 10.3747/co.25.3883] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 7.8] [Reference Citation Analysis]
11 Dy SM, Apostol CC. Evidence-based approaches to other symptoms in advanced cancer. Cancer J 2010;16:507-13. [PMID: 20890148 DOI: 10.1097/PPO.0b013e3181f45877] [Cited by in Crossref: 21] [Cited by in F6Publishing: 5] [Article Influence: 1.9] [Reference Citation Analysis]
12 Vaughan VC, Martin P, Lewandowski PA. Cancer cachexia: impact, mechanisms and emerging treatments. J Cachexia Sarcopenia Muscle. 2013;4:95-109. [PMID: 23097000 DOI: 10.1007/s13539-012-0087-1] [Cited by in Crossref: 102] [Cited by in F6Publishing: 101] [Article Influence: 10.2] [Reference Citation Analysis]
13 Talenezhad N, Mohammadi M, Ramezani-jolfaie N, Mozaffari-khosravi H, Salehi-abargouei A. Effects of l-carnitine supplementation on weight loss and body composition: A systematic review and meta-analysis of 37 randomized controlled clinical trials with dose-response analysis. Clinical Nutrition ESPEN 2020;37:9-23. [DOI: 10.1016/j.clnesp.2020.03.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
14 Baba MR, Buch SA. Revisiting Cancer Cachexia: Pathogenesis, Diagnosis, and Current Treatment Approaches. Asia Pac J Oncol Nurs 2021;8:508-18. [PMID: 34527780 DOI: 10.4103/apjon.apjon-2126] [Reference Citation Analysis]
15 Gerich ME, Isfort RW, Brimhall B, Siegel CA. Medical Marijuana for Digestive Disorders: High Time to Prescribe? American Journal of Gastroenterology 2015;110:208-14. [DOI: 10.1038/ajg.2014.245] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 5.1] [Reference Citation Analysis]
16 Mehrzad V, Afshar R, Akbari M. Pentoxifylline treatment in patients with cancer cachexia: A double-blind, randomized, placebo-controlled clinical trial. Adv Biomed Res 2016;5:60. [PMID: 27135029 DOI: 10.4103/2277-9175.179182] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
17 Wallengren O, Bosaeus I, Lundholm K. Dietary energy density, inflammation and energy balance in palliative care cancer patients. Clinical Nutrition 2013;32:88-92. [DOI: 10.1016/j.clnu.2012.05.023] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
18 Arends J, Strasser F, Gonella S, Solheim TS, Madeddu C, Ravasco P, Buonaccorso L, de van der Schueren MAE, Baldwin C, Chasen M, Ripamonti CI; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Cancer cachexia in adult patients: ESMO Clinical Practice Guidelines. ESMO Open 2021;6:100092. [PMID: 34144781 DOI: 10.1016/j.esmoop.2021.100092] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
19 Graf SA, Garcia JM. Anamorelin hydrochloride in the treatment of cancer anorexia-cachexia syndrome: design, development, and potential place in therapy. Drug Des Devel Ther. 2017;11:2325-2331. [PMID: 28848326 DOI: 10.2147/dddt.s110131] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
20 Anderson LJ, Albrecht ED, Garcia JM. Update on Management of Cancer-Related Cachexia. Curr Oncol Rep 2017;19:3. [PMID: 28138933 DOI: 10.1007/s11912-017-0562-0] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 6.0] [Reference Citation Analysis]
21 Marx W, Teleni L, Opie RS, Kelly J, Marshall S, Itsiopoulos C, Isenring E. Efficacy and Effectiveness of Carnitine Supplementation for Cancer-Related Fatigue: A Systematic Literature Review and Meta-Analysis. Nutrients 2017;9:E1224. [PMID: 29112178 DOI: 10.3390/nu9111224] [Cited by in Crossref: 18] [Cited by in F6Publishing: 8] [Article Influence: 3.6] [Reference Citation Analysis]
22 Anderson LJ, Chong N, Migula D, Sauer A, Garrison M, Wu P, Dash A, Garcia JM. Muscle mass, not radiodensity, predicts physical function in cancer patients with or without cachexia. Oncotarget 2020;11:1911-21. [PMID: 32499874 DOI: 10.18632/oncotarget.27594] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Zhao Y, Pang D, Lu Y. The Role of Nurse in the Multidisciplinary Management of Cancer Cachexia. Asia Pac J Oncol Nurs 2021;8:487-97. [PMID: 34527778 DOI: 10.4103/apjon.apjon-2123] [Reference Citation Analysis]
24 Kaltenborn A, Schrem H, Reichert B, Braun F, Emmanouilidis N, Klempnauer J, Becker T, Heits N. The Glasgow Prognostic Score and its variants predict mortality in living donor but not in deceased donor liver transplantation for hepatocellular carcinoma: A double-center validation study. Hepatol Res 2017;47:783-92. [PMID: 27598002 DOI: 10.1111/hepr.12818] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
25 Mueller TC, Burmeister MA, Bachmann J, Martignoni ME. Cachexia and pancreatic cancer: Are there treatment options? World J Gastroenterol 2014; 20(28): 9361-9373 [PMID: 25071331 DOI: 10.3748/wjg.v20.i28.9361] [Cited by in F6Publishing: 33] [Reference Citation Analysis]
26 Sato R, Oikawa M, Kakita T, Okada T, Abe T, Yazawa T, Tsuchiya H, Akazawa N, Sato M, Ohira T, Harada Y, Okano H, Ito K, Tsuchiya T. The prognostic value of the prognostic nutritional index and inflammation-based markers in obstructive colorectal cancer. Surg Today 2020;50:1272-81. [PMID: 32346761 DOI: 10.1007/s00595-020-02007-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
27 Del Fabbro E. More is better: a multimodality approach to cancer cachexia. Oncologist 2010;15:119-21. [PMID: 20133501 DOI: 10.1634/theoncologist.2010-0019] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
28 Zanetti M, Gortan Cappellari G, Barazzoni R, Sanson G. The Impact of Protein Supplementation Targeted at Improving Muscle Mass on Strength in Cancer Patients: A Scoping Review. Nutrients 2020;12:E2099. [PMID: 32708527 DOI: 10.3390/nu12072099] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Moyad MA. Rapid Review of Breast Cancer Treatment Side Effects and Dietary Supplement/Integrative Options from A to Z: What Helps, Harms, or Does Nothing? Integrative Medicine for Breast Cancer. Cham: Springer International Publishing; 2016. pp. 225-342. [DOI: 10.1007/978-3-319-23422-9_7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
30 Ebner N, Springer J, Kalantar-Zadeh K, Lainscak M, Doehner W, Anker SD, von Haehling S. Mechanism and novel therapeutic approaches to wasting in chronic disease. Maturitas 2013;75:199-206. [PMID: 23664695 DOI: 10.1016/j.maturitas.2013.03.014] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 3.9] [Reference Citation Analysis]
31 Wallengren O, Lundholm K, Bosaeus I. Diagnostic criteria of cancer cachexia: relation to quality of life, exercise capacity and survival in unselected palliative care patients. Support Care Cancer 2013;21:1569-77. [DOI: 10.1007/s00520-012-1697-z] [Cited by in Crossref: 93] [Cited by in F6Publishing: 88] [Article Influence: 10.3] [Reference Citation Analysis]
32 Spence S, Doonan J, Farhan-Alanie OM, Chan CD, Tong D, Cho HS, Sahu MA, Traub F, Gupta S; mGPS Study Group. Does the modified Glasgow Prognostic Score aid in the management of patients undergoing surgery for a soft-tissue sarcoma? : an international multicentre study. Bone Joint J 2022;104-B:168-76. [PMID: 34969280 DOI: 10.1302/0301-620X.104B1.BJJ-2021-0874.R1] [Reference Citation Analysis]
33 Yennurajalingam S, Willey JS, Palmer JL, Allo J, Del Fabbro E, Cohen EN, Tin S, Reuben JM, Bruera E. The role of thalidomide and placebo for the treatment of cancer-related anorexia-cachexia symptoms: results of a double-blind placebo-controlled randomized study. J Palliat Med. 2012;15:1059-1064. [PMID: 22880820 DOI: 10.1089/jpm.2012.0146] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 4.3] [Reference Citation Analysis]
34 Chang W, Hsieh B, Cheng H, Lee K, Chang K. Progesterone augments epirubicin-induced apoptosis in HA22T/VGH cells by increasing oxidative stress and upregulating Fas/FasL. Journal of Surgical Research 2014;188:432-41. [DOI: 10.1016/j.jss.2014.01.063] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
35 Hariyanto TI, Kurniawan A. Appetite problem in cancer patients: Pathophysiology, diagnosis, and treatment. Cancer Treat Res Commun 2021;27:100336. [PMID: 33607591 DOI: 10.1016/j.ctarc.2021.100336] [Reference Citation Analysis]
36 Madeddu C, Mantovani G, Gramignano G, Macciò A. Advances in pharmacologic strategies for cancer cachexia. Expert Opin Pharmacother 2015;16:2163-77. [PMID: 26330024 DOI: 10.1517/14656566.2015.1079621] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
37 Ju R, Wu D, Guo L, Li J, Ye C, Zhang D. Inhibition of pro-inflammatory cytokines in tumour associated macrophages is a potential anti-cancer mechanism of carboxyamidotriazole. European Journal of Cancer 2012;48:1085-95. [DOI: 10.1016/j.ejca.2011.06.050] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
38 Del Fabbro E. Current and Future Care of Patients with the Cancer Anorexia-Cachexia Syndrome. American Society of Clinical Oncology Educational Book 2015. [DOI: 10.14694/edbook_am.2015.35.e229] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
39 Dunne RF, Loh KP, Williams GR, Jatoi A, Mustian KM, Mohile SG. Cachexia and Sarcopenia in Older Adults with Cancer: A Comprehensive Review. Cancers (Basel) 2019;11:E1861. [PMID: 31769421 DOI: 10.3390/cancers11121861] [Cited by in Crossref: 56] [Cited by in F6Publishing: 43] [Article Influence: 18.7] [Reference Citation Analysis]
40 Solheim TS, Laird BJ. Evidence base for multimodal therapy in cachexia. Curr Opin Support Palliat Care 2012;6:424-31. [PMID: 23111703 DOI: 10.1097/SPC.0b013e328359b668] [Cited by in Crossref: 33] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
41 Crawford J, Prado CM, Johnston MA, Gralla RJ, Taylor RP, Hancock ML, Dalton JT. Study Design and Rationale for the Phase 3 Clinical Development Program of Enobosarm, a Selective Androgen Receptor Modulator, for the Prevention and Treatment of Muscle Wasting in Cancer Patients (POWER Trials). Curr Oncol Rep 2016;18:37. [PMID: 27138015 DOI: 10.1007/s11912-016-0522-0] [Cited by in Crossref: 82] [Cited by in F6Publishing: 71] [Article Influence: 16.4] [Reference Citation Analysis]
42 Tuca A, Jimenez-Fonseca P, Gascón P. Clinical evaluation and optimal management of cancer cachexia. Crit Rev Oncol Hematol. 2013;88:625-636. [PMID: 23953794 DOI: 10.1016/j.critrevonc.2013.07.015] [Cited by in Crossref: 62] [Cited by in F6Publishing: 51] [Article Influence: 6.9] [Reference Citation Analysis]
43 Kouchaki B, Janbabai G, Alipour A, Ala S, Borhani S, Salehifar E. Randomized double-blind clinical trial of combined treatment with megestrol acetate plus celecoxib versus megestrol acetate alone in cachexia-anorexia syndrome induced by GI cancers. Support Care Cancer 2018;26:2479-89. [DOI: 10.1007/s00520-018-4047-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
44 Dennis RA, Johnson LE, Roberson PK, Heif M, Bopp MM, Garner KK, Padala KP, Padala PR, Dubbert PM, Sullivan DH. Changes in activities of daily living, nutrient intake, and systemic inflammation in elderly adults receiving recuperative care. J Am Geriatr Soc 2012;60:2246-53. [PMID: 23176675 DOI: 10.1111/jgs.12007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
45 McMillan DC. The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer. Cancer Treat Rev. 2013;39:534-540. [PMID: 22995477 DOI: 10.1016/j.ctrv.2012.08.003] [Cited by in Crossref: 633] [Cited by in F6Publishing: 635] [Article Influence: 63.3] [Reference Citation Analysis]
46 Naito T. Evaluation of the True Endpoint of Clinical Trials for Cancer Cachexia. Asia Pac J Oncol Nurs 2019;6:227-33. [PMID: 31259217 DOI: 10.4103/apjon.apjon_68_18] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
47 Rosenthal MD, Bala T, Wang Z, Loftus T, Moore F. Chronic Critical Illness Patients Fail to Respond to Current Evidence-Based Intensive Care Nutrition Secondarily to Persistent Inflammation, Immunosuppression, and Catabolic Syndrome. JPEN J Parenter Enteral Nutr 2020;44:1237-49. [PMID: 32026502 DOI: 10.1002/jpen.1794] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
48 Busquets S, Serpe R, Toledo M, Betancourt A, Marmonti E, Orpí M, Pin F, Capdevila E, Madeddu C, López-Soriano FJ. L-Carnitine: an adequate supplement for a multi-targeted anti-wasting therapy in cancer. Clin Nutr. 2012;31:889-895. [PMID: 22608917 DOI: 10.1016/j.clnu.2012.03.005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
49 Reid J, Mills M, Cantwell M, Cardwell CR, Murray LJ, Donnelly M. Thalidomide for managing cancer cachexia. Cochrane Database Syst Rev. 2012;CD008664. [PMID: 22513961 DOI: 10.1002/14651858.cd008664.pub2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
50 Kanat O, Cubukcu E, Avci N, Budak F, Ercan I, Canhoroz M, Olmez F. Comparison of Three Different Treatment Modalities in the Management of Cancer Cachexia. Tumori 2013;99:229-33. [DOI: 10.1177/030089161309900218] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 3.8] [Reference Citation Analysis]
51 Nibali L, Fedele S, D’aiuto F, Donos N. Interleukin-6 in oral diseases: a review: IL-6 and oral diseases. Oral Diseases 2012;18:236-43. [DOI: 10.1111/j.1601-0825.2011.01867.x] [Cited by in Crossref: 93] [Cited by in F6Publishing: 91] [Article Influence: 8.5] [Reference Citation Analysis]
52 Rogers ES, Sasidharan R, Sequeira GM, Wood MR, Bird SP, Keogh JW, Arroll B, Stewart J, Macleod RD. A multi‐targeted treatment approach to cancer cachexia: Auckland's Cancer Cachexia evaluating Resistance Training (ACCeRT) trial. JCSM Rapid Communications 2020;3:11-24. [DOI: 10.1002/rco2.10] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
53 Schmidinger M. Understanding and managing toxicities of vascular endothelial growth factor (VEGF) inhibitors. EJC Suppl. 2013;11:172-191. [PMID: 26217127 DOI: 10.1016/j.ejcsup.2013.07.016] [Cited by in Crossref: 64] [Cited by in F6Publishing: 61] [Article Influence: 9.1] [Reference Citation Analysis]
54 Madeddu C, Dessì M, Panzone F, Serpe R, Antoni G, Cau MC, Montaldo L, Mela Q, Mura M, Astara G. Randomized phase III clinical trial of a combined treatment with carnitine + celecoxib ± megestrol acetate for patients with cancer-related anorexia/cachexia syndrome. Clin Nutr. 2012;31:176-182. [PMID: 22047681 DOI: 10.1016/j.clnu.2011.10.005] [Cited by in Crossref: 71] [Cited by in F6Publishing: 65] [Article Influence: 6.5] [Reference Citation Analysis]
55 Thoresen L, Frykholm G, Lydersen S, Ulveland H, Baracos V, Birdsell L, Falkmer U. The association of nutritional assessment criteria with health-related quality of life in patients with advanced colorectal carcinoma: Nutritional assessment and quality of life. European Journal of Cancer Care 2012;21:505-16. [DOI: 10.1111/j.1365-2354.2012.01327.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 3.5] [Reference Citation Analysis]
56 Ronga I, Gallucci F, Riccardi F, Uomo G. Anorexia-cachexia syndrome in pancreatic cancer: recent advances and new pharmacological approach. Adv Med Sci. 2014;59:1-6. [PMID: 24797965 DOI: 10.1016/j.advms.2013.11.001] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
57 Donohoe CL, Ryan AM, Reynolds JV. Cancer cachexia: mechanisms and clinical implications. Gastroenterol Res Pract. 2011;2011:601434. [PMID: 21760776 DOI: 10.1155/2011/601434] [Cited by in Crossref: 127] [Cited by in F6Publishing: 111] [Article Influence: 11.5] [Reference Citation Analysis]
58 Inglis JE, Lin PJ, Kerns SL, Kleckner IR, Kleckner AS, Castillo DA, Mustian KM, Peppone LJ. Nutritional Interventions for Treating Cancer-Related Fatigue: A Qualitative Review. Nutr Cancer 2019;71:21-40. [PMID: 30688088 DOI: 10.1080/01635581.2018.1513046] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
59 Baldwin C. The effectiveness of nutritional interventions in malnutrition and cachexia. Proc Nutr Soc 2015;74:397-404. [DOI: 10.1017/s0029665115002311] [Cited by in Crossref: 21] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
60 Davis M, Lasheen W, Walsh D, Mahmoud F, Bicanovsky L, Lagman R. A Phase II dose titration study of thalidomide for cancer-associated anorexia. J Pain Symptom Manage. 2012;43:78-86. [PMID: 21640548 DOI: 10.1016/j.jpainsymman.2011.03.007] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
61 Penet MF, Winnard PT Jr, Jacobs MA, Bhujwalla ZM. Understanding cancer-induced cachexia: imaging the flame and its fuel. Curr Opin Support Palliat Care 2011;5:327-33. [PMID: 21986909 DOI: 10.1097/SPC.0b013e32834c49ba] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
62 Currow DC, Skipworth RJ. The emerging role of anamorelin hydrochloride in the management of patients with cancer anorexia-cachexia. Future Oncol 2017;13:1767-83. [PMID: 28621564 DOI: 10.2217/fon-2017-0141] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
63 Nabavi SF, Bilotto S, Russo GL, Orhan IE, Habtemariam S, Daglia M, Devi KP, Loizzo MR, Tundis R, Nabavi SM. Omega-3 polyunsaturated fatty acids and cancer: lessons learned from clinical trials. Cancer Metastasis Rev. 2015;34:359-380. [PMID: 26227583 DOI: 10.1007/s10555-015-9572-2] [Cited by in Crossref: 61] [Cited by in F6Publishing: 52] [Article Influence: 10.2] [Reference Citation Analysis]
64 Patil CR, Dhamne NA, Tanawade PK, Mestri NB. Megestrol Acetate in the Treatment of Post COVID-19 Fatigue in a Patient of Advanced Cancer: A Case Report and Mini Review of Literature. Indian J Med Paediatr Oncol. [DOI: 10.1055/s-0042-1742616] [Reference Citation Analysis]
65 Assi M, Rébillard A. The Janus-Faced Role of Antioxidants in Cancer Cachexia: New Insights on the Established Concepts. Oxid Med Cell Longev 2016;2016:9579868. [PMID: 27642498 DOI: 10.1155/2016/9579868] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
66 Haß U, Herpich C, Norman K. Anti-Inflammatory Diets and Fatigue. Nutrients 2019;11:E2315. [PMID: 31574939 DOI: 10.3390/nu11102315] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
67 Mochamat, Cuhls H, Marinova M, Kaasa S, Stieber C, Conrad R, Radbruch L, Mücke M. A systematic review on the role of vitamins, minerals, proteins, and other supplements for the treatment of cachexia in cancer: a European Palliative Care Research Centre cachexia project. J Cachexia Sarcopenia Muscle 2017;8:25-39. [PMID: 27897391 DOI: 10.1002/jcsm.12127] [Cited by in Crossref: 57] [Cited by in F6Publishing: 50] [Article Influence: 9.5] [Reference Citation Analysis]
68 Prommer EE. Palliative Pharmacotherapy: State-of-the-Art Management of Symptoms in Patients With Cancer. Cancer Control 2015;22:403-11. [PMID: 26678967 DOI: 10.1177/107327481502200406] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
69 Donovan KA, Stein KD, Lee M, Leach CR, Ilozumba O, Jacobsen PB. Systematic review of the Multidimensional Fatigue Symptom Inventory-Short Form. Support Care Cancer 2015;23:191-212. [DOI: 10.1007/s00520-014-2389-7] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 4.4] [Reference Citation Analysis]
70 Couch ME, Dittus K, Toth MJ, Willis MS, Guttridge DC, George JR, Chang EY, Gourin CG, Der-Torossian H. Cancer cachexia update in head and neck cancer: Pathophysiology and treatment. Head Neck 2015;37:1057-72. [PMID: 24634283 DOI: 10.1002/hed.23696] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
71 Chang PH, Yeh KY, Wang CH, Chen EY, Yang SW, Huang JS, Chou WC, Hsieh JC. Impact of the pretreatment Glasgow prognostic score on treatment tolerance, toxicities, and survival in patients with advanced head and neck cancer undergoing concurrent chemoradiotherapy. Head Neck 2017;39:1990-6. [PMID: 28688124 DOI: 10.1002/hed.24853] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
72 Penna F, Bonelli G, Baccino FM, Costelli P. Mechanism-Based Therapeutic Approaches to Cachexia. Anorexia. Elsevier; 2013. pp. 271-99. [DOI: 10.1016/b978-0-12-410473-0.00011-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
73 Solheim TS, Vagnildhaug OM, Laird BJ, Balstad TR. Combining optimal nutrition and exercise in a multimodal approach for patients with active cancer and risk for losing weight: Rationale and practical approach. Nutrition 2019;67-68:110541. [PMID: 31470259 DOI: 10.1016/j.nut.2019.06.022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
74 Le-Rademacher JG, Storrick EM, Jatoi A. Remarks on the design and analyses of longitudinal studies for cancer patients with anorexia and weight loss. J Cachexia Sarcopenia Muscle 2019;10:1175-82. [PMID: 31429197 DOI: 10.1002/jcsm.12480] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
75 Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F, Fearon K, Hütterer E, Isenring E, Kaasa S, Krznaric Z, Laird B, Larsson M, Laviano A, Mühlebach S, Muscaritoli M, Oldervoll L, Ravasco P, Solheim T, Strasser F, de van der Schueren M, Preiser JC. ESPEN guidelines on nutrition in cancer patients. Clin Nutr 2017;36:11-48. [PMID: 27637832 DOI: 10.1016/j.clnu.2016.07.015] [Cited by in Crossref: 937] [Cited by in F6Publishing: 816] [Article Influence: 156.2] [Reference Citation Analysis]
76 Hetzler KL, Hardee JP, Puppa MJ, Narsale AA, Sato S, Davis JM, Carson JA. Sex differences in the relationship of IL-6 signaling to cancer cachexia progression. Biochim Biophys Acta 2015;1852:816-25. [PMID: 25555992 DOI: 10.1016/j.bbadis.2014.12.015] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 3.6] [Reference Citation Analysis]
77 Di Sebastiano KM, Yang L, Zbuk K, Wong RK, Chow T, Koff D, Moran GR, Mourtzakis M. Accelerated muscle and adipose tissue loss may predict survival in pancreatic cancer patients: the relationship with diabetes and anaemia. Br J Nutr. 2013;109:302-312. [PMID: 23021109 DOI: 10.1017/s0007114512001067] [Cited by in Crossref: 88] [Cited by in F6Publishing: 43] [Article Influence: 8.8] [Reference Citation Analysis]
78 Cruciani RA, Zhang JJ, Manola J, Cella D, Ansari B, Fisch MJ. L-carnitine supplementation for the management of fatigue in patients with cancer: an eastern cooperative oncology group phase III, randomized, double-blind, placebo-controlled trial. J Clin Oncol 2012;30:3864-9. [PMID: 22987089 DOI: 10.1200/JCO.2011.40.2180] [Cited by in Crossref: 64] [Cited by in F6Publishing: 29] [Article Influence: 6.4] [Reference Citation Analysis]
79 Sugimoto M, Farnell MB, Nagorney DM, Kendrick ML, Truty MJ, Smoot RL, Chari ST, Moynagh MR, Petersen GM, Carter RE, Takahashi N. Decreased Skeletal Muscle Volume Is a Predictive Factor for Poorer Survival in Patients Undergoing Surgical Resection for Pancreatic Ductal Adenocarcinoma. J Gastrointest Surg. 2018;22:831-839. [PMID: 29392613 DOI: 10.1007/s11605-018-3695-z] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
80 Chang X, Zhu Y, Shi C, Stewart AK. Mechanism of immunomodulatory drugs' action in the treatment of multiple myeloma. Acta Biochim Biophys Sin (Shanghai) 2014;46:240-53. [PMID: 24374776 DOI: 10.1093/abbs/gmt142] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 3.9] [Reference Citation Analysis]
81 Solheim TS, Laird BJA, Balstad TR, Stene GB, Bye A, Johns N, Pettersen CH, Fallon M, Fayers P, Fearon K, Kaasa S. A randomized phase II feasibility trial of a multimodal intervention for the management of cachexia in lung and pancreatic cancer. J Cachexia Sarcopenia Muscle 2017;8:778-88. [PMID: 28614627 DOI: 10.1002/jcsm.12201] [Cited by in Crossref: 124] [Cited by in F6Publishing: 119] [Article Influence: 24.8] [Reference Citation Analysis]
82 Naito T. Emerging Treatment Options For Cancer-Associated Cachexia: A Literature Review. Ther Clin Risk Manag 2019;15:1253-66. [PMID: 31754304 DOI: 10.2147/TCRM.S196802] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
83 Jo H, Yoshida T, Horinouchi H, Yagishita S, Matsumoto Y, Shinno Y, Okuma Y, Goto Y, Yamamoto N, Takahashi K, Motoi N, Ohe Y. Prognostic significance of cachexia in advanced non-small cell lung cancer patients treated with pembrolizumab. Cancer Immunol Immunother 2021. [PMID: 34180007 DOI: 10.1007/s00262-021-02997-2] [Reference Citation Analysis]
84 Muscaritoli M, Molfino A, Lucia S, Rossi Fanelli F. Cachexia: a preventable comorbidity of cancer. A T.A.R.G.E.T. approach. Crit Rev Oncol Hematol 2015;94:251-9. [PMID: 25468676 DOI: 10.1016/j.critrevonc.2014.10.014] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 6.1] [Reference Citation Analysis]
85 Alesi ER, del Fabbro E. Opportunities for targeting the fatigue-anorexia-cachexia symptom cluster. Cancer J 2014;20:325-9. [PMID: 25299142 DOI: 10.1097/PPO.0000000000000065] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
86 Mäkitie AA, Alabi RO, Orell H, Youssef O, Almangush A, Homma A, Takes RP, López F, de Bree R, Rodrigo JP, Ferlito A. Managing Cachexia in Head and Neck Cancer: a Systematic Scoping Review. Adv Ther. [DOI: 10.1007/s12325-022-02074-9] [Reference Citation Analysis]
87 Reid J, Hughes CM, Murray LJ, Parsons C, Cantwell MM. Non-steroidal anti-inflammatory drugs for the treatment of cancer cachexia: a systematic review. Palliat Med. 2013;27:295-303. [PMID: 22450159 DOI: 10.1177/0269216312441382] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
88 Palma CGL, Lera AT, Lerner T, de Oliveira MM, de Borta TM, Barbosa RP, Brito GM, Guazzelli CA, Cruz FJM, del Giglio A. Guarana ( Paullinia cupana ) Improves Anorexia in Patients with Advanced Cancer. Journal of Dietary Supplements 2015;13:221-31. [DOI: 10.3109/19390211.2015.1008612] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
89 Suzuki T, Ebner N, Palus S, Haehling S, Springer J. Progesterone improves survival in hepatoma cachexia rat model. JCSM Rapid Communications 2020;3:3-10. [DOI: 10.1002/rco2.11] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
90 Porporato PE. Understanding cachexia as a cancer metabolism syndrome. Oncogenesis. 2016;5:e200. [PMID: 26900952 DOI: 10.1038/oncsis.2016.3] [Cited by in Crossref: 224] [Cited by in F6Publishing: 210] [Article Influence: 37.3] [Reference Citation Analysis]
91 Dy GK, Adjei AA. Understanding, recognizing, and managing toxicities of targeted anticancer therapies. CA Cancer J Clin. 2013;63:249-279. [PMID: 23716430 DOI: 10.3322/caac.21184] [Cited by in Crossref: 187] [Cited by in F6Publishing: 174] [Article Influence: 20.8] [Reference Citation Analysis]
92 Fathizadeh H, Milajerdi A, Reiner Ž, Amirani E, Asemi Z, Mansournia MA, Hallajzadeh J. The effects of L-carnitine supplementation on indicators of inflammation and oxidative stress: a systematic review and meta-analysis of randomized controlled trials. J Diabetes Metab Disord 2020;19:1879-94. [PMID: 33520867 DOI: 10.1007/s40200-020-00627-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
93 Zang Y, Fang Z, Li B. Erlotinib Plus Parenteral Nutrition: An Opportunity to Get Through the Hardest Days of Advanced Non-Small Cell Lung Cancer With Cancer Anorexia–Cachexia Syndrome. Am J Hosp Palliat Care 2013;30:210-3. [DOI: 10.1177/1049909113476930] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
94 Kreher M. Symptom Control at the End of Life. Med Clin North Am 2016;100:1111-22. [PMID: 27542430 DOI: 10.1016/j.mcna.2016.04.020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
95 Ishida J, Saitoh M, Doehner W, von Haehling S, Anker M, Anker SD, Springer J. Animal models of cachexia and sarcopenia in chronic illness: Cardiac function, body composition changes and therapeutic results. International Journal of Cardiology 2017;238:12-8. [DOI: 10.1016/j.ijcard.2017.03.154] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
96 Lai HY, Chang HT, Lee YL, Hwang SJ. Association between inflammatory markers and frailty in institutionalized older men. Maturitas 2014;79:329-33. [PMID: 25132319 DOI: 10.1016/j.maturitas.2014.07.014] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
97 Nakayama M, Tabuchi K, Hara A. Clinical utility of the modified Glasgow prognostic score in patients with advanced head and neck cancer. Head Neck 2015;37:1745-9. [PMID: 24989115 DOI: 10.1002/hed.23823] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
98 Douglas E, McMillan DC. Towards a simple objective framework for the investigation and treatment of cancer cachexia: the Glasgow Prognostic Score. Cancer Treat Rev 2014;40:685-91. [PMID: 24321611 DOI: 10.1016/j.ctrv.2013.11.007] [Cited by in Crossref: 75] [Cited by in F6Publishing: 70] [Article Influence: 8.3] [Reference Citation Analysis]
99 Ausoni S, Calamelli S, Saccà S, Azzarello G. How progressive cancer endangers the heart: an intriguing and underestimated problem. Cancer Metastasis Rev 2020;39:535-52. [PMID: 32152913 DOI: 10.1007/s10555-020-09869-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
100 Li Q, Liu Y, Yu Y. Antiangiogenic therapy for primitive neuroectodermal tumor with thalidomide: A case report and review of literature. Medicine (Baltimore) 2017;96:e9272. [PMID: 29390485 DOI: 10.1097/MD.0000000000009272] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
101 Ma Y, Liu L, Xiao J, Cao B. Perioperative ω -3 Polyunsaturated Fatty Acid Nutritional Support in Gastrointestinal Cancer Surgical Patients: A Systematic Evaluation. Nutrition and Cancer 2016;68:568-76. [DOI: 10.1080/01635581.2016.1158291] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
102 Tan CR, Yaffee PM, Jamil LH, Lo SK, Nissen N, Pandol SJ, Tuli R, Hendifar AE. Pancreatic cancer cachexia: a review of mechanisms and therapeutics. Front Physiol. 2014;5:88. [PMID: 24624094 DOI: 10.3389/fphys.2014.00088] [Cited by in Crossref: 49] [Cited by in F6Publishing: 55] [Article Influence: 6.1] [Reference Citation Analysis]
103 Cruciani RA, Revuelta M, Dvorkin E, Homel P, Lesage P, Esteban-Cruciani N. L-carnitine supplementation in patients with HIV/AIDS and fatigue: a double-blind, placebo-controlled pilot study. HIV AIDS (Auckl) 2015;7:65-73. [PMID: 25733927 DOI: 10.2147/HIV.S66695] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
104 Tuca Rodríguez A, Calsina-berna A, González-barboteo J, Gómez-batiste Alentorn X. Caquexia en cáncer. Medicina Clínica 2010;135:568-72. [DOI: 10.1016/j.medcli.2010.06.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
105 Macciò A, Madeddu C, Mantovani G. Current pharmacotherapy options for cancer anorexia and cachexia. Expert Opin Pharmacother. 2012;13:2453-2472. [PMID: 23072481 DOI: 10.1517/14656566.2012.734297] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
106 Suzuki H, Asakawa A, Amitani H, Nakamura N, Inui A. Cancer cachexia--pathophysiology and management. J Gastroenterol 2013;48:574-94. [PMID: 23512346 DOI: 10.1007/s00535-013-0787-0] [Cited by in Crossref: 115] [Cited by in F6Publishing: 101] [Article Influence: 12.8] [Reference Citation Analysis]
107 Macciò A, Madeddu C. Inflammation and ovarian cancer. Cytokine 2012;58:133-47. [PMID: 22349527 DOI: 10.1016/j.cyto.2012.01.015] [Cited by in Crossref: 159] [Cited by in F6Publishing: 154] [Article Influence: 15.9] [Reference Citation Analysis]
108 Anderson LJ, Lee J, Mallen MC, Migula D, Liu H, Wu PC, Dash A, Garcia JM. Evaluation of physical function and its association with body composition, quality of life and biomarkers in cancer cachexia patients. Clin Nutr 2021;40:978-86. [PMID: 32713720 DOI: 10.1016/j.clnu.2020.07.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
109 Argilés JM, Busquets S, López-Soriano FJ. Anti-inflammatory therapies in cancer cachexia. Eur J Pharmacol 2011;668 Suppl 1:S81-6. [PMID: 21835173 DOI: 10.1016/j.ejphar.2011.07.007] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 4.3] [Reference Citation Analysis]
110 Wu C, Zhu M, Lu Z, Zhang Y, Li L, Li N, Yin L, Wang H, Song W, Xu H. L-carnitine ameliorates the muscle wasting of cancer cachexia through the AKT/FOXO3a/MaFbx axis. Nutr Metab (Lond) 2021;18:98. [PMID: 34724970 DOI: 10.1186/s12986-021-00623-7] [Reference Citation Analysis]
111 Turcott JG, Zatarain-Barrón ZL, Cárdenas Fernández D, Castañares Bolaños DT, Arrieta O. Appetite stimulants for patients with cancer: current evidence for clinical practice. Nutr Rev 2021:nuab045. [PMID: 34389868 DOI: 10.1093/nutrit/nuab045] [Reference Citation Analysis]
112 Yeh KY, Wang HM, Chang JW, Huang JS, Lai CH, Lan YJ, Wu TH, Chang PH, Wang H, Wu CJ, Hsia S, Wang CH. Omega-3 fatty acid-, micronutrient-, and probiotic-enriched nutrition helps body weight stabilization in head and neck cancer cachexia. Oral Surg Oral Med Oral Pathol Oral Radiol 2013;116:41-8. [PMID: 23562359 DOI: 10.1016/j.oooo.2013.01.015] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
113 Knight K, Choong JX, McKee RF, Anderson JH, Horgan PG, McMillan DC, McDonald A, Roxburgh CS. The Influence of Systemic Inflammation on Treatment Response and Survival in Anal Squamous Cell Cancer. Clin Oncol (R Coll Radiol) 2021;33:e22-30. [PMID: 32709540 DOI: 10.1016/j.clon.2020.06.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]